Diagnostics
News and analysis on diagnostic technologies and applications.
Centogene to Sell Business to Private Equity Group for €8.7M, Liquidate Remaining Subsidiaries
Charme Capital Partners will acquire complete ownership of Centogene GmbH and will assume Centogene's loan from Oxford Finance.
Natera Q3 Revenues Grow 64 Percent
Strong product sales, mainly from oncology tests, drove the company's revenue growth, prompting it to raise its full year guidance.
Grail Q3 Revenues Rise 39 Percent
Grail reported that strong sales of its blood-based Galleri cancer early detection test drove revenue growth in its first operating quarter as a public company.
The company expects its five-marker LucentAD Complete test to offer higher performance than single-marker assay and to secure higher reimbursement.
Investigators found that they could increase CNS infection diagnoses by using metagenomic next-generation sequencing to test cerebrospinal fluid samples.